Clinical-stage company developing gene therapies for severe genetic and rare diseases.
Issues related to the implementation of 21st century cures; issues related to novel therapies for rare pediatric populations; H.R. 1628, The American Health Care Act of 2017. Issues related to Medicaid and CHIP as it relates to rare pediatric diseases. Monitored H.R. 1628, The American Health Care Act of 2017 and issues related to Medicaid and high risk populations. S. Con. Res. 3, FY '17 Budget Resolution.
HCR - Health Issues MMM - Medicare/Medicaid BUD - Budget/Appropriations
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
THE NICKLES GROUP, LLC
601 13th St. NW, Suite 250 N, Washington, DC, 20005, US
STACEY HUGHES EMILY PORTER EMILY PORTER STACEY HUGHES EMILY PORTER STACEY HUGHES